Mayo Clinic and TGen ID potential targets for the most-deadly form of pancreatic cancer
PHOENIX and SCOTTSDALE, Ariz. — Sept. 14, 2020 — A team of researchers led by Mayo Clinic and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified specific potential therapeutic targets for the most aggressive and lethal form of pancreatic cancer. In what is believed to be the most comprehensive…